Preventing catheter-related infections in children undergoing hemodialysis

References

• Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis.19(1), 1–8 (2000).
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin. Dial.20, 440–451 (2007).
   PubMed Web of Science ®Google Scholar
• Weijmer MC, Vervloet MG, Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol. Dial. Transplant.19, 670–677 (2004).
   PubMedGoogle Scholar
• Thomson P, Stirling C, Traynor J, Morris S, Mactier R. A prospective observational study of catheter-related bacteraemia and thrombosis in a haemodialysis cohort: univariate and multivariate analyses of risk association. Nephrol. Dial. Transplant.25(5), 1596–1604 (2010).
   PubMedGoogle Scholar
• Blot SI, Depuydt P, Annemans L et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin. Infect. Dis.1(41), 1591–1598 (2005).
   Google Scholar
• Burr R, Marszalek J, Saul M, Shields M, Aslam N. The cost of vascular access infections: three years experience from a single outpatient dialysis center. Hemodial. Int.7, 73–104 (2003).
   PubMedGoogle Scholar
• Fischbach M, Edefonti A, Schröder C, Watson A; The European Pediatric Dialysis Working Group. Hemodialysis in children: general practical guidelines. Pediatr. Nephrol.20, 1054–1066 (2005).
   PubMedGoogle Scholar
• Fadrowski JJ, Hwang W, Neu AM, Fivush BA, Furth SL. Patterns of use of vascular catheters for hemodialysis in children in the United States. Am. J. Kidney Dis.53, 91–98 (2009).
   PubMedGoogle Scholar
• Stefanidis CJ. Prevention of catheter-related bacteremia in children on hemodialysis: time for action Pediatr. Nephrol.24, 2087–2095 (2009).
   PubMedGoogle Scholar
• Fadrowski JJ, Hwang W, Frankenfield DL, Fivush BA, Neu AM, Furth SL. Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: findings from the Clinical Performance Measures and US Renal Data System projects. Clin. J. Am. Soc. Nephrol.1, 987–992 (2006).
   PubMedGoogle Scholar
• Zaritsky JJ, Salusky IB, Gales B et al. Vascular access complications in long-term pediatric hemodialysis patients. Pediatr. Nephrol.23(11), 2061–2065 (2008).
   PubMedGoogle Scholar
• Wasse H, Kutner N, Zhang R, Huang Y. Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin. J. Am. Soc. Nephrol.2, 708–714 (2007).
   PubMed Web of Science ®Google Scholar
• Zaritsky JJ, Salusky IB, Gales B et al. Vascular access complications in long-term pediatric hemodialysis patients. Pediatr. Nephrol.23(11), 2061–2065 (2008).
   PubMedGoogle Scholar
• National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy, and vascular access. Am. J. Kidney Dis.48(Suppl. 1), S1–S322 (2006).
   Web of Science ®Google Scholar
• Sherertz RJ, Ely EW, Westbrook DM et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann. Intern. Med.132, 641–648 (2000).
   PubMed Web of Science ®Google Scholar
• Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J. Am. Soc. Nephrol.18, 952–959 (2007).
   PubMed Web of Science ®Google Scholar
• US Renal Data System: USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA (2004).
   Google Scholar
• Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis population 1991 to 1999. J. Am. Soc. Nephrol.15, 1038–1045 (2004).
   PubMed Web of Science ®Google Scholar
• Aslam N, Bernardini J, Fried L, Burr R, Piraino B. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol.6, 1226–1233 (2006).
   Google Scholar
• Saxena AK, Panhorota BR, Al-Mulhim AS. Vascular access related infections in hemodialysis patients. Saudi J. Kidney Dis. Transplant.16, 46–71 (2005).
   PubMedGoogle Scholar
• Beathard GA. Catheter management protocol for catheter-related bacteremia prophylaxis. Semin. Dial.16, 403–405 (2003).
   PubMedGoogle Scholar
• Hannah EL, Stevenson KB, Lowder CA et al. Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect. Control Hosp. Epidemiol.23, 538–541 (2002).
   PubMedGoogle Scholar
• Sharma A, Zilleruelo G, Abitbol C, Montane B, Strauss J. Survival and complications of cuffed catheters in children on chronic hemodialysis. Pediatr. Nephrol.13(3), 245–248 (1999).
   PubMed Web of Science ®Google Scholar
• Sheth RD, Kale AS, Brewer ED, Brandt ML, Nuchtern JG, Goldstein SL. Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis. Am. J. Kidney Dis.38(3), 553–559 (2001).
   PubMedGoogle Scholar
• Ramage IJ, Bailie A, Tyerman KS, McColl JH, Pollard SG, Fitzpatrick MM. Vascular access survival in children and young adults receiving long-term hemodialysis. Am. J. Kidney Dis.45(4), 708–714 (2005).
   PubMedGoogle Scholar
• Fadel FI, Abdel Mooty HN, Bazaraa HM, Sabry SM. Central venous catheters as a vascular access modality for pediatric hemodialysis. Int. Urol. Nephrol.40(2), 489–496 (2008).
   PubMedGoogle Scholar
• Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR. Hemodialysis catheter-related bacteremia in children: increasing antibiotic resistance and changing bacteriological profile. Am. J. Kidney Dis.50(1), 119–123 (2007).
   PubMedGoogle Scholar
• Peynircioglu B, Ozkan F, Canyigit M et al. Radiologically placed tunneled internal jugular catheters in the management of chronic hemodialysis and long-term infusion therapies in the pediatric population. J. Vasc. Interv. Radiol.18(7), 875–881 (2007).
   PubMedGoogle Scholar
• Onder AM, Chandar J, Billings A et al. Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia. Pediatr. Nephrol.24(9), 1741–1747 (2009).
   PubMedGoogle Scholar
• George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH. Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study. Br. Med. J.17(332), 1435 (2006).
   Google Scholar
• Klevens RM, Tokars JI, Andrus M. Electronic reporting of infections associated with hemodialysis. Nephrol. News Issues19, 37–38 (2005).
   PubMedGoogle Scholar
• Beathard GA, Urbanes A. Infection associated with tunneled hemodialysis catheters. Semin. Dial.21(6), 528–538 (2008).
   PubMedGoogle Scholar
• Trautner B, Darouiche R. Catheter-associated infections. Arch. Intern. Med.164, 842–850 (2004).
   PubMedGoogle Scholar
• Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection, I: Pathogenesis and short-term devices. Clin. Infect. Dis.34, 1232–1342 (2002).
   PubMedGoogle Scholar
• Suojanen JN, Brophy DP, Nasser I. Thrombus on indwelling central venous catheters: the histopathology of ‘fibrin sheaths’. Cardiovasc. Intervent. Radiol.23, 194–197 (2000).
   PubMedGoogle Scholar
• Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA271, 1014–1016 (1994).
   PubMed Web of Science ®Google Scholar
• Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J. Am. Soc. Nephrol.9(5), 869–876 (1998).
   PubMed Web of Science ®Google Scholar
• Chawla PG, Nevins TE. Management of hemodialysis catheter-related bacteremia – a 10-year experience. Pediatr. Nephrol.14, 198–202 (2000).
   PubMedGoogle Scholar
• Donlan RM. Biofilms microbial life on surfaces. Emerg. Infect. Dis.9, 881–890 (2002).
   Google Scholar
• Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. J. Clin. Invest.112, 1466–1477 (2003).
   PubMed Web of Science ®Google Scholar
• Rijnders BJ, Van Wijngaerden E, Van Eldere J, Peetermans WE. Polyclonal Staphylococcus epidermidis intravascular catheter related infections. Clin. Microbiol. Infect.7, 388–391 (2001).
   PubMedGoogle Scholar
• Donlan RM. Biofilms microbial life on surfaces. Emerg. Infect. Dis.9, 881–890 (2002).
   Google Scholar
• Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am. J. Kidney Dis.4, 779–791 (2004).
   Google Scholar
• Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled hemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol. Dial. Transplant.21, 1024–1031 (2006).
   PubMed Web of Science ®Google Scholar
• Canaud B, Sénécal L, Leray-Moragués H et al. Vascular access, an underestimated cause of inflammation in hemodialysis patient. Néphrologie24, 353–358 (2003).
   PubMedGoogle Scholar
• Oliver MJ, Callery SM, Thorpe KE et al. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int.58, 2543–2545 (2000).
   PubMed Web of Science ®Google Scholar
• Lemaire X, Morena M, Leray-Moragués H et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif.28(1), 21–28 (2009).
   PubMed Web of Science ®Google Scholar
• Jean G, Charra B, Chazot C et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron91(3), 399–405 (2002).
   PubMed Web of Science ®Google Scholar
• Adeniyi OA, Tzamaloukas AH. Relation between access-related infection and preinfection serum albumin concentration in patients on chronic hemodialysis. Hemodial. Int.7(4), 304–310 (2003).
   PubMedGoogle Scholar
• Powe NR, Jaar B, Furth SL. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int.55, 1081–1090 (1999).
   PubMed Web of Science ®Google Scholar
• Aslam N, Bernardini J, Fried L, Burr R, Piraino B. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol.1(6), 1226–1233 (2006).
   PubMed Web of Science ®Google Scholar
• Onder AM, Chandar J, Coakley S, Abitbol C, Montane B, Zilleruelo G. Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis. Pediatr. Nephrol.21(10), 1452–1458 (2006).
   PubMedGoogle Scholar
• Brewster UC, Coca SG, Reilly RF, Perazella MA. Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection. Nephrology (Carlton)10, 124–128 (2005).
   PubMedGoogle Scholar
• Sirken G, Raja R, Rizkala AR. Identification of infectious risk factors in maintenance hemodialysis patients: the role of intravenous iron. J. Am. Soc. Nephrol.15, 627A (2004).
   Google Scholar
• Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis.32, 1249–1272 (2001).
   PubMed Web of Science ®Google Scholar
• Schwab SJ, Beathard GA. The hemodialysis catheter conundrum: hate living with them, but can’t live without them. Kidney Int.56, 1–17 (1999).
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis.49, 1–45 (2009).
   PubMed Web of Science ®Google Scholar
• DesJardin J. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann. Intern. Med.131, 641–647 (1999).
   PubMed Web of Science ®Google Scholar
• Vanholder R, Canaud B, Fluck R et al. Diagnosis, prevention and treatment of haemodialysis catheter-related blood stream infections (CRBSI): a position statement of European Renal Best Practice (ERBP). NDT Plus3, 234–246 (2010).
   PubMedGoogle Scholar
• Vanholder R, Canaud B, Fluck R et al. Catheter-related blood stream infections (CRBSI): a European view. Nephrol. Dial. Transplant.25(6), 1753–1756 (2010).
   PubMed Web of Science ®Google Scholar
• Allon M. Saving infected catheters: why and how. Blood Purif.23, 23–28 (2005).
   PubMedGoogle Scholar
• Marr KA, Sexton D, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann. Intern. Med.127, 275–280 (1997).
   PubMed Web of Science ®Google Scholar
• Messing B, Peitra-Cohen S, Beliah M, Bernier J. Antibiotic- lock technique: an approach to optimal therapy for catheter-related sepsis in home parenteral nutrition patients. JPEN J. Parenter. Enteral. Nutr.12(2), 185–189 (1988).
   PubMed Web of Science ®Google Scholar
• Manierski C, Besarab A. Antimicrobial locks: putting the lock on catheter infections. Adv. Chronic Kidney Dis.13, 245–258 (2006).
   PubMedGoogle Scholar
• Capdevila JA, Segarra A, Planes AM et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol. Dial. Transplant.8, 231–234 (1993).
   PubMed Web of Science ®Google Scholar
• Poole CV, Carolton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol. Dial. Transplant.19, 1237–1244 (2004).
   PubMed Web of Science ®Google Scholar
• Onder AM, Chandar J, Simon N et al. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks. Pediatr. Nephrol.23, 457–464 (2008).
   PubMedGoogle Scholar
• Onder AM, Chandar J, Coakley S, Abitbol C, Montane B, Zilleruelo G. Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis. Pediatr. Nephrol.21(10), 1452–1458 (2006).
   PubMedGoogle Scholar
• Johnson DW, MacGinley R, Kay TD et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol. Dial. Transplant.17, 1802–1807 (2002).
   PubMed Web of Science ®Google Scholar
• Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J. Am. Soc. Nephrol.13, 169–179 (2003).
   Google Scholar
• Beathard GA. Catheter management protocol for catheter-related bacteremia prophylaxis. Semin. Dial.16, 403–405 (2003).
   PubMedGoogle Scholar
• O’Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm. Rep.51, 1–29 (2002).
   PubMedGoogle Scholar
• Shanks RM, Donegan NP, Graber ML et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun.73, 4596–4606 (2005).
   PubMed Web of Science ®Google Scholar
• Weijmer MC, van den Dorpel MA, Van de Ven PJ et al.; CITRATE Study Group. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol.16, 2769–2777 (2005).
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. FDA issues warning on tricitrasol dialysis catheter anticoagulant. FDA talk paper TOO-16, April 14. US Food and Drug Administration, MD, USA (2000).
   Google Scholar
• Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous hemodialysis catheters – an effective, more cost-efficient alternative to heparin. Nephrol. Dial. Transplant.22, 471–476 (2007).
   PubMed Web of Science ®Google Scholar
• Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin. Infect. Dis.36, 1539–1544 (2003).
   PubMed Web of Science ®Google Scholar
• Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate–taurolidine-containing lock solution. Nephrol. Dial. Transplant.19, 1546–1551 (2004).
   PubMed Web of Science ®Google Scholar
• Solomon LR, Cheesbrough JS, Ebah L et al. A randomized double-blind controlled trial of taurolidine–citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am. J. Kidney Dis.5(6), 1060–1068 (2010).
   Google Scholar
• Simon A, Ammann RA, Wiszniewsky G, Bode U, Fleischhack G, Besuden MM. Taurolidine–citrate lock solution (TauroLock) significantly reduces CVAD-associated Grampositive infections in pediatric cancer patients. BMC Infect. Dis.29(8), 102 (2008).
   Google Scholar
• Dogra GK, Herson H, Hutchison B et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J. Am. Soc. Nephrol.13, 2133–2139 (2002).
   PubMed Web of Science ®Google Scholar
• Saxena AK, Panhotra BR, Naguib M. Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy22, 105–108 (2002).
   PubMedGoogle Scholar
• McIntyre CW, Hulme LJ, Taal M. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int.66, 801–805 (2004).
   PubMed Web of Science ®Google Scholar
• Saxena AK, Panhotra BR, Sundaram DS et al. Tunneled catheters’ outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int.70, 1629–1635 (2006).
   PubMed Web of Science ®Google Scholar
• Chiou PF, Chang C, Wen YK, Yang Y. Antibiotic lock technique reduces the incidence of temporary catheter related infections. Clin. Nephrol.65(29), 419–422 (2006).
   PubMedGoogle Scholar
• Bleyer AJ. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin. J. Am. Soc. Nephrol.2, 1073–1078 (2007).
   PubMed Web of Science ®Google Scholar
• Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline–EDTA) in temporary hemodialysis access. Infect. Control Hosp. Epidemiol.26, 520–524 (2005).
   PubMed Web of Science ®Google Scholar
• Ingram LO, Buttke TM. Effects of alcohols on micro-organisms. Adv. Microb. Physiol.25, 253–300 (1984).
   PubMed Web of Science ®Google Scholar
• Percival SL, Kite P. Intravascular catheters and biofilm control. J. Vasc. Access8, 69–80 (2007).
   PubMed Web of Science ®Google Scholar
• Takla TA, Zelenitsky SA, Vercaigne LM. Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections. J. Vasc. Access8(4), 262–267 (2007).
   PubMedGoogle Scholar
• Takla TA, Zelenitsky SA, Vercaigne LM. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J. Antimicrob. Chemother.62(5), 1024–1026 (2008).
   PubMedGoogle Scholar
• Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J. Pediatr. Hematol. Oncol.25, 616–621 (2003).
   PubMed Web of Science ®Google Scholar
• Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch. Pediatr. Adolesc. Med.160, 1049–1053 (2006).
   PubMedGoogle Scholar
• Ackoundou-N’guessan C, Heng AE, Guenu S et al. Ethanol lock solution as an adjunct treatment for preventing recurrent catheter-related sepsis – first case report in dialysis setting. Nephrol. Dial. Transplant.21(11), 3339–3340 (2006).
   PubMedGoogle Scholar
• Broom JK, O’Shea S, Govindarajulu S et al. Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in haemodialysis patients. BMC Nephrol.20(10), 23 (2009).
   Google Scholar
• Cooper R, Saad T. Prevention of bacteraemia in patients with tunnelled cuffed ‘permanent’ hemodialysis catheters (PCs) using gentamicin catheter packing. J. Am. Soc. Nephrol.10, 203A (1999).
   PubMedGoogle Scholar
• Zhang P, Zhang W, He Q et al. A randomized controlled study on prevention of cuff-tunneled catheter related bacteremia with gentamicin-heparin lock solution: the metaphase result. J. Am. Soc. Nephrol.17, 592A (2006).
   Google Scholar
• Pervez A, Ahmed M, Ram S et al. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J. Vasc. Access3, 108–113 (2002).
   PubMedGoogle Scholar
• Al-Hwiesh AK, Abdul-Rahman IS. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin. Saudi J. Kidney Dis. Transpl.18, 239–247 (2007).
   PubMedGoogle Scholar
• Kim SH, Song KI, Chang JW. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int.69, 161–164 (2006).
   PubMed Web of Science ®Google Scholar
• Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am. J. Kidney Dis.48, 596–605 (2006).
   PubMed Web of Science ®Google Scholar
• James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann. Intern. Med.148, 596–605 (2008).
   PubMed Web of Science ®Google Scholar
• Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol. Dial. Transplant.23, 1666–1672 (2008).
   PubMed Web of Science ®Google Scholar
• Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin. Infect. Dis.47, 83–93 (2008).
   PubMed Web of Science ®Google Scholar
• Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am. J. Kidney Dis.51, 233–241 (2008).
   PubMed Web of Science ®Google Scholar
• Guerraoui AA, Dacosta EE, Roche BB. Emergence of multiresistant Staphylococcus epidermidis (MRSE) after lock antibiotic regimen by gentamicin in permanent hemodialysis catheters. Prospective study, 1999–2003. J. Am. Soc. Nephrol.15, 368A (2004).
   Google Scholar
• Centers for Disease Control and Prevention. Monitoring hospital acquired infections to promote patient safety – United States, 1990–1999. MMWR Morb. Mortal. Wkly Rep.49, 149–153 (2000).
   PubMedGoogle Scholar